Estradiol (E) primes human endometrial stromal cells (HESCs) for the decidualizing effects of progesterone in vivo and in vitro. Matrix metalloproteinase (MMP) expression was evaluated in confluent HESCs incubated in control medium, and in medium supplemented with either E, or the synthetic progestin medroxyprogesterone acetate (P), or E ϩ P. Measurements with a specific ELISA indicated that basal pro-MMP-1 output was unaffected by E, whereas E ϩ P, which induces the expression of several decidualization-related markers, produced a time-dependent inhibition in HESC-secreted levels of pro-MMP-1. Consistent with progestin inhibition of MMP-1 protein expression in the HESCs, P but not E, reduced steady state levels of MMP-1 messenger RNA (mRNA) as determined by Northern analysis. By contrast, mRNA levels for MMP-2 and the MMP inhibitor TIMP-1 were not altered by either P or E. Steroid withdrawal studies indicated that after MMP-1 expression was suppressed by incubation of the HESCs with E ϩ P, 4 days of exposure to the antiprogestin RU 486 (mifepristone) significantly up-regulated MMP-1 levels in the conditioned medium by severalfold compared with cultures maintained in E ϩ P. The change to steroid-free control medium required a more prolonged period of withdrawal to attain up regulatory effects that were comparable with those evoked by RU 486. The ELISA measurements were validated by immunoblot analysis with a specific MMP-1 antibody, which showed corresponding changes in a band at the expected mobility of about 50 kDa. Moreover, Northern analysis revealed parallel changes in MMP-1 mRNA levels, whereas neither MMP-2 nor TIMP-1 mRNA levels were modulated by adding or withdrawing steroids. The contrast between regulated MMP-1 expression and constitutive MMP-2 expression observed in the cultured HESCs is consistent with the demonstrated presence on the MMP-1 promoter of regulatory elements such as AP-1 and PEA-3 that are absent from the MMP-2 promoter. Extrapolation of these in vitro changes in HESCs to in vivo endometrial events suggests that: 1) inhibition of MMP-1 expression by E and progesterone would stabilize the perivascular endometrial ECM to prevent local hemorrhage during endovascular invasion by the implanting trophoblast; 2) enhanced expression of MMP-1 evoked by steroid withdrawal would mediate endometrial ECM degradation leading to sloughing of the functional layer during menstruation. (Endocrinology 139: [4607][4608][4609][4610][4611][4612][4613] 1998) D ECIDUALIZATION, the program of growth, biochemical, and morphologic differentiation by which decidual cells arise from stromal cells, epitomizes the extensive cyclical changes that characterize the steroid-responsive functional layer of the human endometrium. Progesterone stimulates estradiol (E)-primed human endometrial stromal cells (HESCs) to decidualize. This process is initiated around the spiral arterioles and subsequently spreads throughout the endometrium of the late luteal phase and pregnancy (1). During decidualization, the interstitial type extracellular matrix (ECM) of the follicular phase endometrium, which is enriched in fibronectin and collagen types I, III, V, and VI, is converted to a mixture of residual interstitial proteins and new peri-decidual basal laminar type components (2). The latter includes laminin, heparin sulfate proteoglycan, and collagen type IV (3-5). This transformation involves stromal/decidual cell-mediated turnover of ECM components. The resulting ECM plays an integral role in implantation by modulating migration of the invading trophoblast. In nonfertile cycles, a consequence of the widespread occurrence of decidualization throughout the late luteal phase endometrium is that decidualized stromal cells are well positioned to mediate proteolytic degradation of the endometrial ECM leading to menstruation.
D ECIDUALIZATION, the program of growth, biochemical, and morphologic differentiation by which decidual cells arise from stromal cells, epitomizes the extensive cyclical changes that characterize the steroid-responsive functional layer of the human endometrium. Progesterone stimulates estradiol (E)-primed human endometrial stromal cells (HESCs) to decidualize. This process is initiated around the spiral arterioles and subsequently spreads throughout the endometrium of the late luteal phase and pregnancy (1) . During decidualization, the interstitial type extracellular matrix (ECM) of the follicular phase endometrium, which is enriched in fibronectin and collagen types I, III, V, and VI, is converted to a mixture of residual interstitial proteins and new peri-decidual basal laminar type components (2) . The latter includes laminin, heparin sulfate proteoglycan, and collagen type IV (3) (4) (5) . This transformation involves stromal/decidual cell-mediated turnover of ECM components. The resulting ECM plays an integral role in implantation by modulating migration of the invading trophoblast. In nonfertile cycles, a consequence of the widespread occurrence of decidualization throughout the late luteal phase endometrium is that decidualized stromal cells are well positioned to mediate proteolytic degradation of the endometrial ECM leading to menstruation.
The matrix metalloproteinases (MMPs) degrade the bulk of ECM components during tissue remodeling. Based on substrate specificity, the MMPs are grouped into: 1) collagenases, which regulate interstitial ECM turnover by degrading interstitial collagens types I, II, and III via a specific cleavage that denatures the helical structure of these fibrillar collagens; 2) gelatinases, which degrade basement membrane collagens IV and V as well as denatured interstitial collagens (gelatins); and 3) stromelysins, which degrade such diverse ECM proteins as proteoglycans, glycoproteins, fi-bronectin, and laminin, and can cleave the globular domain of interstitial (type III) and basement membrane collagen type IV and V (6 -8) .
Previous studies showed that progestins inhibited, and E plus progestin markedly inhibited, stromelysin-1 (MMP-3) expression in monolayers of HESCs, whereas the cells were refractory to E added alone (9, 10) . These responses mimic differential ovarian steroids effects on the induction of decidualization in vivo in which E primes the endometrium for the differentiating effects of progesterone by enhancing progesterone receptor levels (11, 12) . Moreover, the progestininhibited expression of MMP-3 was reversed by steroid withdrawal (9) . This response to removal of steroid stimulation suggests that in vitro decidualized HESCs constitute a relevant model for menstruation, which is initiated by steroid withdrawal. Thus, decidual cell-expressed MMP-3 would be expected to promote ECM degradation preceding sloughing of the functional layer.
Fibrillar collagens are key components of the endometrial ECM during trophoblast invasion and at the time of menstruation. Denaturation of these collagens by interstitial collagenase (MMP-1) is mandatory for further processing by stromelysins, such as MMP-3, and gelatinases, such as the 72-kDa gelatinase-A (MMP-2) (7, 8) . The current study sought to determine whether MMP-1 and MMP-2 expression conformed to the pattern established for MMP-3 during progestin-regulated in vitro decidualization and after subjecting in vitro decidualized HESCs to steroid withdrawal. The in vitro measurements were extended to include the tissue inhibitor of matrix metalloproteinase (TIMP-1) to evaluate its potential role in regulating MMP activity. The effects of the antiprogestin-antiglucocorticoid RU 486 (mifepristone) were tested in the in vitro menstruation model because accelerated up-regulation in stromal/decidual cell MMP activity is consistent with enhanced endometrial ECM breakdown leading to the excess uterine bleeding that complicates the use of RU 486 as an abortifacient (13, 14) .
Materials and Methods

Tissues and stromal cell isolation
Endometrial specimens were obtained from patients undergoing hysterectomy for myomas who had given informed consent. The specimens were transported on ice to a sterile laminar flow hood in the laboratory. A small portion was formalin-fixed for later dating by the histologic criteria of Noyes et al. (15) . Stromal cells were isolated from the remainder of each specimen (16) . Their purity has been confirmed by immunocytochemical staining for cytokeratin and vimentin (17) .
Experimental culture conditions
As previously described (16, 17) , HESCs, isolated from two specimens of proliferative phase tissue and ten specimens of early secretory phase tissue, were grown to confluence (3-4 ϫ 10 4 cells/cm 2 ) in a 37 C, 95% air:5% CO 2 incubator in BMS, which consists of BM [a phenol red-free 1:1 vol:vol mix of DMEM (Gibco BRL, Grand Island, NY) and Ham's F-12 (Flow Laboratories, Rockville, MD), with 100 U/ml penicillin, 100 g/ml streptomycin, 0.25 g/ml fungizone] supplemented with 10% charcoal-stripped calf serum (S).
Steroid specificity and time course
The experimental period was initiated in either fresh BMS, or in a serum-free defined medium (DM) [ 
Steroid withdrawal
Using the protocol outlined in Fig. 1 , confluent HESCs were incubated in BMS containing 10 Ϫ8 m Ϫ1 E and 10 Ϫ7 m Ϫ1 medroxyprogesterone acetate (P) in the 37 C incubator, replacing the medium every 3-5 days. After 10 days, the cultures were washed twice with BMS, and steroid withdrawal was carried out for 4 days in BMS containing either vehicle control, or 10 Ϫ6 m Ϫ1 RU 486, while parallel cultures were maintained in 10 Ϫ8 m Ϫ1 E plus 10 Ϫ7 m Ϫ1 P. In some experiments the steroid withdrawal protocol was modified by carrying out withdrawal; 1) for additional 4-and 8-day intervals, or 2) in parallel in either BMS, or in DM, or 3) with onapristone (Schering AG, Berlin, Germany) substituted for RU 486, or 4) in medium containing E ϩ P ϩ RU 486. The experiments were terminated as described above, storing the centrifuged conditioned medium at Ϫ70 C, and harvesting the cells for total protein and DNA measurements. Parallel cultures were washed with HBSS and frozen at Ϫ70 C for Northern analysis.
Immunoblot analysis
Conditioned medium was mixed with Laemmli sample buffer containing 5% 2-mercaptoethanol, subjected to 7% PAGE, then electrotransferred onto nitrocellulose. After blocking nonspecific sites with 3% powdered low fat milk, the blots were incubated with a specific anti-MMP-1 rabbit polyclonal antibody, generously supplied by Dr. M. Lark (Merck Research Laboratories, Rahway, NJ). The blots were washed, exposed to [ 125 I] protein-A (200,000 cpm/ml) for 30 min, washed three times and subjected to autoradiography.
MMP-1 ELISA
Stromal cell conditioned medium was assayed for immunoreactive MMP-1 levels by a specific ELISA according to the manufacturer's specifications (Oncogene Research Products, Inc., Cambridge, MA).
Protein and DNA assay
Protein and DNA content of the cell pellets was determined by a modified Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA), and by the method of Hinegardner (18), respectively. 32 P]deoxy-CTP to high specific activity by random priming with a Boehringer Mannheim kit. Hybridization was performed by standard methods as previously described (19) , and the washed filters were exposed to Kodak XAR film. (Eastman Kodak Co., Rochester, NY). Total RNA loads were standardized by reprobing the stripped membranes with either 32 P-labeled probes for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (CLONTECH Laboratories, Inc., Palo Alto, CA) (19) , or cyclophylin (20) .
Northern analysis
Statistical analysis
Statistical comparisons were made with the Mann-Whitney Rank Sum Test with P Ͻ 0.05 considered significant.
Results
MMP and TIMP-1 expression during in vitro decidualization of HESCs
Culture medium and time course. Previous reports showing progestin-elicited up-regulation of tissue factor (17, 21) and the type-1 plasminogen activator inhibitor (PAI-1) (22, 23) in BMS and in DM during steroid-regulated decidualization prompted us to investigate whether these media would mediate steroid effects on MMP-1 expression in the HESCs. Figure 2 compares immunoreactive pro-MMP-1 levels in the conditioned medium of HESCs incubated in parallel in BMS or DM supplemented with E, or medroxyprogesterone acetate (P), or E ϩ P. Secreted levels of pro-MMP-1, were reduced in response to P but not to E, with greater inhibition resulting from coincubation with E ϩ P in BMS. While progestin-mediated inhibition of pro-MMP-1 was evident in both media, pro-MMP-1 output was considerably greater in BMS. The effects of E and E ϩ P were also studied on HESCsecreted levels of pro-MMP-1, during incubation in BMS for three consecutive 4-to 5-day intervals (Fig. 3) . Virtually complete inhibition was evident by 14 days in response to E ϩ P, which simulates the duration of endometrial exposure to E and progesterone during the luteal phase.
Steroid specificity. The synthetic progestin, P is commonly used to induce decidualization-related changes in vitro because of its stability in culture (24) . Although P can exhibit glucocorticoid effects in some cell systems (25) , this was not the case for MMP-1 expression by HESCs. Thus, ELISA measurements in cultures incubated in BMS showed that E ϩ P markedly inhibited pro-MMP-1 output by cultured HESCs (Ͼ90%), whereas neither dexamthasone (Dex) nor E ϩ Dex was inhibitory (results not shown). These observations are consistent with our previous reports showing that enhancement of tissue factor (21) and PAI-1 (23) expression by HESC monolayers was under progestin but not glucocorticoid control. Further emphasizing the progestin specificity of inhibited MMP-1 expression in the cultured HESCs, the Northern blot shown in Fig. 4 confirms that P, but not E, inhibited steady state levels of MMP-1 mRNA. However, neither E nor P altered levels of MMP-2 or TIMP-1 mRNA (Fig. 4) .
Steroid withdrawal effects on MMP and TIMP-1 expression in decidualized stromal cells
Effects on MMP and TIMP mRNA levels. The scheme outlined in Fig. 1 was used to compare the effects of steroid withdrawal on MMP-1, MMP-2, and TIMP-1 mRNA levels with those previously established for MMP-3 mRNA (26). Northern blot analysis (Fig. 5) shows that after suppressing both MMP-1 and MMP-3 mRNA levels during 10 days of incubation with E ϩ P, 8 days of steroid withdrawal to control BMS up-regulated steady state levels of both mRNAs compared with parallel cultures maintained in E ϩ P. As expected, more effective up-regulation occurred when the progesterone receptor antagonist RU 486 (14, 27, 28) was added alone or with E ϩ P to the culture medium. Unlike the changes seen for MMP-1 and MMP-3 mRNA, levels of MMP-2 and TIMP-1 mRNA in the HESCs were unaffected by steroid withdrawal to either control or to RU 486-containing medium.
Effects on MMP-1 protein levels. After confluent HESCs were incubated with E ϩ P for 10 days, immunoblot analysis was used to measure levels of pro-MMP-1 in the medium of parallel cultures either kept in E ϩ P or subjected to the steroid withdrawal protocol outlined in Fig. 1 . The immunoblot of Fig. 6 shows that at the end of the 0 -4 day withdrawal interval, compared with cultures maintained in E ϩ P, secreted levels of pro-MMP-1 (about 50 kDa) were markedly increased whether the medium was supplemented with RU 486 added alone or with E ϩ P. However, only marginal up-regulation resulted from withdrawal to steroid-free control medium. During the subsequent 4 -8 days of withdrawal, the change to control medium was now nearly as effective as RU 486 in increasing pro-MMP-1 levels (Fig. 6) . The latter effect is consistent with removal of residual steroid from the cultures during the additional medium change and prolonged incubation of the second withdrawal interval.
Use of a specific MMP-1 ELISA quantitatively confirmed the immunoblot results of Fig. 6 . Figure 7A shows that after the 0 -4 day steroid withdrawal interval, secreted pro-MMP-1 levels were no different in parallel cultures of HESCs that were either maintained in E ϩ P or withdrawn to steroidfree medium (C), whereas RU 486 up-regulated pro-MMP-1 levels by about 5-fold (P Ͻ 0.05, n ϭ 7). At the end of the 8-to 12-day withdrawal interval, RU 486 elicited a further 2.5-to 3-fold increase in secreted MMP-1 levels. Furthermore, the switch to control medium up-regulated secreted MMP-1 to levels that were nearly equivalent with that produced by RU 486. Although RU 486 is an antiprogestin that can also act as an antiglucocorticoid at high concentrations (14) , the purer antiprogestin, onapristone (29) , was as effective as RU 486 in reversing the inhibitory effects of E ϩ P on HESC-secreted MMP-1 levels (results not shown). This observation further emphasizes the progestin specificity of inhibited MMP-1 expression. Figure 7B shows immunogenic levels of pro-MMP-1 in the FIG. 5. Steroid withdrawal effects on MMP-1, MMP-3, MMP-2, and TIMP-1 mRNA levels. Confluent primary HESCs were exposed to 10
Ϫ1 P for 10 days in BMS, then incubated for 8 days in fresh medium containing either vehicle control (C), or E ϩ P, or 10 Ϫ6 M Ϫ1 RU 486 (R), or E ϩ P ϩ R. To normalize for differences in RNA loading of the Northern blot, it was stripped and reprobed for GAPDH, a housekeeping gene that is unresponsive to steroids in the HESCs. conditioned medium of first passage HESCs that were subjected in parallel to steroid withdrawal in either a serumcontaining medium (BMS), or in DM. In BMS, the pattern of secreted pro-MMP-1 was similar to that displayed by primary HESCs (Fig. 7A) . However, pro-MMP-1 levels were much lower in the conditioned medium of first passage than of primary HESCs (Fig. 7B) . For example, the reversal in progestin-inhibited pro-MMP-1 output elicited by RU 486 in primary HESCs (7A) was 30-to 80-fold greater than that elicited in the passaged HESCs during the corresponding withdrawal interval (7B). Moreover, DM failed to support pro-MMP-1 output by the passaged cells. Thus, 7B shows that secreted levels of pro-MMP-1 were greatly reduced in incubations performed in DM compared with BMS, with withdrawal effects attenuated by the end of the 4-to 8-day withdrawal interval (note the difference in ordinate scale between 7A and 7B).
Discussion
The serine protease urokinase (uPA) interacts with the MMPs to efficiently degrade ECM components. Secreted prouPA binds to and is activated at specific cell membrane receptors where it converts plasminogen to plasmin, a serine protease with broader substrate specificity than uPA (30) . Although plasmin can degrade matrices that undergo rapid turnover, it exerts its prime impact on ECM proteolysis by activating MMP zymogens. Activated MMPs can then degrade the slowly remodeled scaffolding structures that comprise the bulk of the ECM (7, 30) . The current study demonstrated that MMP-1 mRNA and protein levels followed a pattern previously established for uPA (22) and MMP-3 (9, 10) expression during in vitro decidualization of primary HESCs (i.e. inhibition by P and greater inhibition by E ϩ P despite a lack of response to E alone). While P can exhibit glucocorticoid effects, and glucocorticoids inhibit MMP-1 expression in several cell types (7, 31) , primary HESCs were refractory to Dex either added alone or with E. Because E specifically elevates PRs (11, 12) , the lack of response to Dex suggests that inhibition of MMP-1 expression is integral to the progestin-regulated decidualization reaction. Recently, we showed that expression of the glucocorticoid metabolizing enzyme 11␤-hydroxysteroid dehydrogenase (11␤-HSD) was enhanced during in vitro decidualization of the HESCs (16) . Circulating cortisol levels exceed those of progesterone during the menstrual cycle (32) . However, local glucocorticoid inactivation by endometrial decidual cell-expressed 11␤-HSD could ensure that progesterone selectively occupies promiscuous steroid response elements on the promoter regions of both the glucocorticoid and progesterone receptor genes.
The simultaneous inhibition of MMP-1, MMP-3, and uPA expression in stromal/decidual cells in response to circulating levels of E and progesterone modulates the composition of the luteal phase and pregnant endometrial ECM. Following implantation, the endometrial ECM promotes trophoblast adhesion, migration and differentiation (33) , yet prevents the trophoblast from penetrating into the myometrium (1). The gestational endometrial ECM also provides structural support for blood vessels, thereby counteracting the threat of local hemorrhage during endovascular trophoblast invasion (34) . In nonfertile cycles, the decline in circulating levels of ovarian steroids stemming from regression of the corpus luteum, initiates menstruation.
The suitability of in vitro decidualized HESCs as a menstruation model was suggested from reports that steroid withdrawal reversed E ϩ P-inhibited uPA activity (23) and pro-MMP-3 levels (26) in HESCs. The action of MMP-1 is required for fibrillar collagen degradation. Therefore, the demonstration in the current study that steroid withdrawal also reverses inhibited MMP-1 expression is a critical addition to the menstruation model because it accounts for degradation of residual interstitial collagens in the peri-decidual cell ECM. Extrapolation of the up-regulation in uPA, MMP-3, and MMP-1 expression by in vitro decidualized HESCs to decidual cells of the perimenstrual endometrium is consistent with ECM degradation leading to sloughing of the functional endometrial layer. The clinical use of RU 486 is complicated by pronounced endometrial ECM degradation and excessive menstrual bleeding (13, 14) . The marked effectiveness of RU 486 in reversing the expression of progestininhibited uPA (23) , and MMP-3 (26) , and as shown in the current study, MMP-1, emphasizes the relevance of in vitro decidualized stromal cells in the screening of antiprogestins for potential menstruation-inducing activity.
In the current study, the profound changes in steady-state levels of MMP-1 and MMP-3 mRNA observed during progestin-mediated decidualization and in decidualized HESCs subjected to steroid withdrawal contrast sharply with the lack of effect on MMP-2 mRNA levels. However, Irwin et al. (35) reported that steroid withdrawal markedly up-regulated MMP-2 expression in cultured HESCs. The explanation for these contradictory results likely lies in differences in the culturing conditions used in the two studies. Thus, Irwin et al. (35) apparently used HESCs obtained after multiple passages that were cultured in a serum-free medium. However, Fig. 7B shows that MMP-1 secretion is markedly reduced after one passage, and that steroid withdrawal effects were much greater in BMS than in DM.
The importance of validating alterations in MMP expression in cultured cells with parallel measurements in vivo is well documented (31, 36) . Toward that end, Rodgers et al. (37) meticulously localized MMP and TIMP mRNA levels to the stromal and epithelial compartments of specimens of cycling human endometrium by in situ hybridization. Their observations support the results of the current study. They demonstrated that MMP-3 mRNA was strongly expressed and MMP-1 mRNA was weakly expressed in the stroma of follicular phase endometrium. Both mRNA species were reduced to nondetectable levels during the progesterone-dominated luteal phase, then up-regulated in correspondence with steroid withdrawal leading to menstruation (37) . By contrast, MMP-2 and TIMP-1 mRNA were maintained at constant levels in the stromal compartment throughout most of the menstrual cycle, with only marginal up-regulation evident in the peri-menstrual period (37). Marbaix et al. (38) provided in vitro support for progestational inhibition of MMP-1 expression in human endometrium by observing that MMP-1 mRNA, protein, and activity were measurable only in explants obtained from the progestin-withdrawal initiated peri-menstrual phase.
Coordinate changes in the expression of the MMP-1 and MMP-3 genes have been attributed to similarities in their promoter regions. These contain 1) a TATA box; 2) at least one AP-1 site, which binds c-fos/c-jun heterodimers; and 3) at least one PEA-3 site, an oncogene response element that responds to the c-ets family of transcription factors. In several cell systems, the combination of AP-1 and PEA-3 sites mediates growth factor and oncogene induction of MMP-1 and MMP-3 gene expression, whereas the corticosteroid-receptor complex can interfere with AP-1-enhanced MMP-1 expression. By contrast, the MMP-2 promoter is devoid of such response elements [see review by Matrisian (31) ]. As expected from the constitutive nature of its promoter, MMP-2 expression is insensitive to exogenous growth factors, cytokines, hormones, and neural cell-adhesion molecules (NCAMs) in several cell types (31, 39) . Unlike the MMP-2 promoter, that of the other member of the gelatinase subclass, the 92-kDa gelatinase-B (MMP-9), contains similar response elements to those found on the MMP-1 and MMP-3 promoters. Predictably, cultured HESCs responded to interleukin 1, tumor necrosis factor, and phorbol myristate acetate with enhanced MMP-1, MMP-3, and MMP-9 gene expression, whereas the MMP-2 gene was unresponsive (40) .
Previous studies described PAI-1 as the primary regulator of progestin-inhibited uPA catalytic activity during both in vitro decidualization of HESCs as well as its subsequent up regulation in response to steroid withdrawal (22, 23) . By contrast, the current study shows that the profound changes in MMP-1 and MMP-3 expression that occur during in vitro decidualization, and after subjecting in vitro decidualized HESCs to steroid withdrawal, were accompanied by unchanging levels of TIMP-1 mRNA. A recent report in which cultured HESCs were primed with a progestin alone extended the absence of a progestin withdrawal effect on HESC-expressed MMP inhibitors to include TIMP-2 and TIMP-3 (41) . Thus, progesterone regulation of HESC/decidual cell-expressed uPA, which promotes degradation of provisional ECM components, occurs secondary to changes in the expression of the PAI-1 inhibitor, whereas the genes for MMP-1 and MMP-3, which promote breakdown of the structural components of the endometrial ECM, are controlled by progesterone without TIMP intervention. Cytokines and growth factors derived from decidual cells, endothelial cells and leukocytes are likely to modulate decidual-expressed proteases during menstruation with trophoblasts serving as an additional source of paracrine effectors during implantation (42) . Identification of autocrine/paracrine agents that interact with ovarian steroids to differentially regulate expression of uPA and MMPs by endometrial stromal/decidual cells presents a major challenge in reproductive biology.
